It can be a difficult process to try and identify the best stocks in the biotechnology world. Each biotech claims to have perfected its relevant science and investors need to look past that and actually decide which ones are contenders and which ones are pretenders. One stock that appears to be on the path to glory is NeoStem (NBS). After a busy week of announcements, it's important for investors to understand each one and their potential impact on the company. But before we analyze them, let's give investors a quick overview of why so many are excited about the future prospects of NeoStem.
NeoStem is one of the top companies in the cellular therapy industry. Cellular...
Only subscribers can access this article, which is part of the PRO research library covering 3,580 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: